FDA Approved: PROCYSBI — Original Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

The FDA approved PROCYSBI (cysteamine bitartrate) under an original application for the treatment of nephropathic cystinosis, providing a new release formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephropathic Cystinosis

Drugs mentioned

• Procysbi (mercaptamine bitartrate)

Snippet

ORIG AP for PROCYSBI (CYSTEAMINE BITARTRATE)